Zobrazeno 1 - 10
of 162
pro vyhledávání: '"Farhad Khimani"'
Autor:
Mazyar Shadman, Kwang W. Ahn, Manmeet Kaur, Lazaros Lekakis, Amer Beitinjaneh, Madiha Iqbal, Nausheen Ahmed, Brian Hill, Nasheed M. Hossain, Peter Riedell, Ajay K. Gopal, Natalie Grover, Matthew Frigault, Jonathan Brammer, Nilanjan Ghosh, Reid Merryman, Aleksandr Lazaryan, Ron Ram, Mark Hertzberg, Bipin Savani, Farrukh Awan, Farhad Khimani, Sairah Ahmed, Vaishalee P. Kenkre, Matthew Ulrickson, Nirav Shah, Mohamed A. Kharfan-Dabaja, Alex Herrera, Craig Sauter, Mehdi Hamadani
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract In patients with relapsed DLBCL in complete remission (CR), autologous hematopoietic cell transplantation (auto-HCT) and CAR-T therapy are both effective, but it is unknown which modality provides superior outcomes. We compared the efficacy
Externí odkaz:
https://doaj.org/article/e8520ed8a9ea4ad4a6eebc0252da84a4
Autor:
Dae Hyun Lee, Sanjay Chandrasekhar, Michael D. Jain, Rahul Mhaskar, Kayla Reid, Sae Bom Lee, Salvatore Corallo, Melanie J. Hidalgo-Vargas, Abhishek Kumar, Julio Chavez, Bijal Shah, Aleksandr Lazaryan, Farhad Khimani, Taiga Nishihori, Christina Bachmeier, Rawan Faramand, Michael G. Fradley, Daniel Jeong, Guilherme H. Oliveira, Frederick L. Locke, Marco L Davila, Mohammed Alomar
Publikováno v:
Cardio-Oncology, Vol 9, Iss 1, Pp 1-9 (2023)
Abstract Background Chimeric antigen receptor T- Cell (CAR-T) immunotherapy has been a breakthrough treatment for various hematological malignancies. However, cardiotoxicities such as new-onset heart failure, arrhythmia, acute coronary syndrome and c
Externí odkaz:
https://doaj.org/article/2b3320c84568447e825867b260a94475
Publikováno v:
Cancers, Vol 16, Iss 3, p 677 (2024)
Fifty years have passed since the development of the first chemotherapy regimen for treating acute myelogenous leukemia (AML), with the approval in 1973 of the cytarabine daunorubicin (7+3) regimen. Until recently, patients diagnosed with AML had ver
Externí odkaz:
https://doaj.org/article/776b2a62e0b143dd8f8b76ef9c1f71f5
Autor:
Turab Mohammed, Moazzam Shahzad, Lauren Peres, Sushmita Khadka, Christelle Colinleitzinger, Abida Babu, William Doyle, Omar Castaneda Puglianini, Laura Oswald, Gabe De Avila, Ariel Grajales-Cruz, Brandon Blue, Jose Ochoa-Bayona, Eric Smith, Salvatore Corallo, Farhad Khimani, Rawan Faramand, Hany Elmariah, Aleksandr Lazaryan, Michael Jain, Hien Liu, Taiga Nishihori, Ken Shain, Rachid Baz, Melissa Alsina, Frederick Locke, Ciara Freeman, Doris Hansen
Publikováno v:
HemaSphere, Vol 7, p e46377e2 (2023)
Externí odkaz:
https://doaj.org/article/3816dc577cf240bcafe0c8f4c6641fec
Autor:
Mohammad Ammad Ud Din, Nayeon Oh, Aliyah Baluch, Olga Klinkova, Rod Quilitz, Melissa Alsina, Nelli Bejanyan, Omar Castaneda, Julio Chavez, Hany Elmariah, Ciara Freeman, Doris Hansen, Michael Jain, Farhad Khimani, Aleksandr Lazaryan, Hien Liu, Asmita Mishra, Leonel Ochoa, Lia Perez, Joseph Pidala, Bijal Shah, Taiga Nishihori, Frederick Locke, Rawan Faramand
Publikováno v:
HemaSphere, Vol 7, p e971246c (2023)
Externí odkaz:
https://doaj.org/article/f564b9060c574acab7f765ec7c3cd8b1
Autor:
Emily Keit MD, Casey Liveringhouse MD, Nicholas Figura MD, Joseph Weygand PhD, Maria L. Sandoval MD, Genevieve Garcia CMD, Julia Peters CMD, Michael Nieder MD, Rawan Faramand MD, Farhad Khimani MD, Sungjune Kim MD, PhD, Timothy J. Robinson MD, PhD, Peter A.S. Johnstone MD, Jose Penagaricano MD, Kujtim Latifi PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Introduction: High-dose total body irradiation (TBI) is often part of myeloablative conditioning in acute leukemia. Modern volumetric modulated arc therapy (VMAT)-based plans employ arcs to the inferior-most portion of the body that can be simulated
Externí odkaz:
https://doaj.org/article/b4ea26ac7d884ff3a7e48f8c1c2c5dd2
Autor:
Aasha I. Hoogland, Reena V. Jayani, Aaron Collier, Nathaly Irizarry‐Arroyo, Yvelise Rodriguez, Michael D. Jain, Margaret Booth‐Jones, Kelly A. Hyland, Brian W. James, Anna Barata, Christina A. Bachmeier, Julio C. Chavez, Farhad Khimani, Gabriel S. Krivenko, Aleksandr Lazaryan, Hien D. Liu, Taiga Nishihori, Javier Pinilla‐Ibarz, Bijal D. Shah, Muneer Abidi, Frederick L. Locke, Heather S. L. Jim
Publikováno v:
Cancer Medicine, Vol 10, Iss 6, Pp 1936-1943 (2021)
Abstract Chimeric antigen receptor T‐cell therapy with axicabtagene ciloleucel (axi‐cel) has considerably improved survival in adults with relapsed/refractory large B‐cell lymphoma. This study reports patient‐reported outcomes (PROs) such as
Externí odkaz:
https://doaj.org/article/4e712b76e8e5405caf6b6c0634f8f50e
Autor:
Narendranath Epperla, Kwang W. Ahn, Carlos Litovich, Sairah Ahmed, Minoo Battiwalla, Jonathon B. Cohen, Parastoo Dahi, Nosha Farhadfar, Umar Farooq, Cesar O. Freytes, Nilanjan Ghosh, Bradley Haverkos, Alex Herrera, Mark Hertzberg, Gerhard Hildebrandt, David Inwards, Mohamed A. Kharfan-Dabaja, Farhad Khimani, Hillard Lazarus, Aleksandr Lazaryan, Lazaros Lekakis, Hemant Murthy, Sunita Nathan, Taiga Nishihori, Attaphol Pawarode, Tim Prestidge, Praveen Ramakrishnan, Andrew R. Rezvani, Rizwan Romee, Nirav N. Shah, Ana Sureda, Timothy S. Fenske, Mehdi Hamadani
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-11 (2019)
Abstract Background There is a paucity of data on the role of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with angioimmunoblastic T-cell lymphoma (AITL). Using the CIBMTR registry, we report here the outcomes of AITL patients
Externí odkaz:
https://doaj.org/article/19ce45d9a24347588db685661d8cf472
Autor:
Sylvia L. Crowder, Rachel Sauls, Laura Redwine, Michael Nieder, Omar Albanyan, Hassaan Yasin, Farhad Khimani, Marilyn Stern
Publikováno v:
Cancers, Vol 14, Iss 11, p 2760 (2022)
Previous adolescent and young adult (AYA) research suggests patients undergoing hematopoietic stem cell transplantation (HSCT) experience severe physiological stress. The goal of this study was to identify unmet needs, interests, and preferences for
Externí odkaz:
https://doaj.org/article/36d27272767f4a149f9743e6fe847909
Autor:
Jennifer M. Logue, Elisa Zucchetti, Christina A. Bachmeier, Gabriel S. Krivenko, Victoria Larson, Daniel Ninh, Giovanni Grillo, Biwei Cao, Jongphil Kim, Julio C. Chavez, Aliyah Baluch, Farhad Khimani, Aleksandr Lazaryan, Taiga Nishihori, Hien D. Liu, Javier Pinilla-Ibarz, Bijal D. Shah, Rawan Faramand, Anna E. Coghill, Marco L. Davila, Bhagirathbhai R. Dholaria, Michael D. Jain, Frederick L. Locke
Publikováno v:
Haematologica, Vol 106, Iss 4 (2020)
CD19 CAR T-cell therapy with axicabtagene ciloleucel (axi-cel) for relapsed or refractory (R/R) large B cell lymphoma (LBCL) may lead to durable remissions, however, prolonged cytopenias and infections may occur. In this single center retrospective s
Externí odkaz:
https://doaj.org/article/9b49d260a7484ec48b00e7dc0cef6f14